You are here: Industry Insights > Black Fungus

News List

Deadly 'Black Fungus' Disease Spotted in Americans With COVID-19 Drugs
December 17, 2021
It's a phenomenon first identified in India earlier this year: Patients who have or are recovering from COVID-19 who then contract a sometimes deadly fungal infection known as mucormycosis -- also known as "black fungus."
Mankind Pharma launches Posaconazole tablets to treat black fungus expresspharma
June 11, 2021
Mankind Pharma has launched Posaconazole Gastro-Resistant tablets with the brand name POSAFORCE 100. Posaconazole gastro-resistant tablets are indicated for treating mucormycosis patients.
Modern Laboratories to produce Amphotericin B to treat black fungus expresspharma
June 01, 2021
The price in the market will be around Rs 3,000, while we will give the government around Rs 1,500, said Anil Kharia, Chairman, Modern Laboratories.
Strides, TLC collaborate to launch black fungus drug in India expresspharma
May 31, 2021
The CDSCO has approved TLC's new drug application (NDA) of Amphotericin B Liposome for Injection 50 mg in India for immediate importation per approved usage and indication.
IIT Hyderabad is ready for tech transfer of oral drug to treat ‘black fungus’ expresspharma
May 31, 2021
A 60-mg tablet, which can be priced at about Rs 200, is patient friendly as its slow and sustained release in the body reduces nephrotoxicity.
Thousands of 'Black Fungus' Cases Reported in COVID-19 Patients in India drugs
May 25, 2021
India is struggling with thousands of cases of deadly fungal infections in COVID-19 patients and those who have recovered from the disease.
MSN Laboratories launches Posaconazole to treat mucormycosis expresspharma
May 24, 2021
MSN has launched the product under the brand name PosaOne as 100 mg Delayed Release tablets and 300 mg injections, respectively.